NSE ScannerComparison · NSE · data 2026-11-01
Dr. Agarwal'S Eye Hospital Limited vs Nephrocare Health Services Limited
In plain words
Size: Nephrocare Health Services Limited is about 2.4 times the market value of Dr. Agarwal'S Eye Hospital Limited.
Return on equity: Dr. Agarwal'S Eye Hospital Limited 25.2% vs Nephrocare Health Services Limited 9%.
Debt to equity: Dr. Agarwal'S Eye Hospital Limited 0.94 vs Nephrocare Health Services Limited 0.07.
Differences in the numbers, not a recommendation of either stock.
Side by side
| DRAGARWQ | NEPHROPLUS | |
|---|---|---|
| Price | ₹5,317.5 | ₹614.55 |
| Market cap | ₹2,552 cr | ₹6,194 cr |
| P/E | 33.5 | — |
| P/B | — | — |
| ROE | 25.2% | 9.0% |
| ROCE | 17.4% | 14.6% |
| Debt / equity | 0.94 | 0.07 |
| Operating margin | 21.1% | — |
| Dividend yield | 0.13% | 0.00% |
| Sales growth, 3 years (yearly) | 20.7% | 31.6% |
| Profit growth, 3 years (yearly) | 23.8% | — |
| 1-year return | 13.1% | 25.4% |
| Revenue, last 12 months | ₹497 cr | — |
| Net profit, last 12 months | ₹76 cr | — |
| Latest quarter | — | Jun 2026 |
| Quarter net profit | — | ₹32 cr |
| Quarter profit vs a year earlier | — | — |
| Promoter holding | — | 58.31% |
| Health check | Strong (8.3/10) | Strong (7.8/10) |
Common questions
Which earns a higher return on equity?
Dr. Agarwal'S Eye Hospital Limited (25.2% against 9.0%).
Which carries more debt?
Dr. Agarwal'S Eye Hospital Limited has the higher debt-to-equity ratio (0.94 against 0.07).